Stocks have fallen due to concerns over us-iran tensions, with astra zeneca's stock also being affected by a trial miss. However, reports of potential diplomatic efforts and comments suggesting the iran conflict may end soon have led to a rebound in stocks. The situation remains volatile, with oil prices and stock markets fluctuating in response to developments in the us-iran situation.